Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential applications. Initial findings suggest that this higher dosage may amplify the drug's ability to regulate blood sugar, potentially offering greater outcomes for individuals with type 2 diabetes. Further study is underway to fully explore the long-term